Detalles de la búsqueda
1.
Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Breast Cancer Res Treat
; 197(2): 287-297, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385236
2.
Changes in HER3 expression profiles between primary and recurrent gynecological cancers.
Cancer Cell Int
; 23(1): 18, 2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36737733
3.
Folate receptor alpha is widely expressed and a potential therapeutic target in uterine and ovarian carcinosarcoma.
Gynecol Oncol
; 176: 115-121, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506533
4.
Discordances in expression of human epidermal growth factor receptor 2 between primary and metastatic uterine carcinosarcoma: A proposal for HER2-targeted therapy specimen selection.
Ann Diagn Pathol
; 65: 152150, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119646
5.
Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
Cancer Sci
; 113(4): 1428-1434, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043515
6.
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.
BMC Cancer
; 22(1): 412, 2022 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35421961
7.
Regional differences in human papillomavirus type 52 prevalence among Japanese women with cervical intraepithelial neoplasia.
Jpn J Clin Oncol
; 52(10): 1242-1247, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35938523
8.
Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.
Int J Clin Oncol
; 26(1): 207-215, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960420
9.
Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma.
Int J Clin Oncol
; 26(7): 1322-1329, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33825085
10.
Treatment strategy for locally advanced squamous cell cervical cancer with clinically positive pelvic lymph nodes metastasis.
J Obstet Gynaecol Res
; 47(7): 2442-2448, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002450
11.
Quality of life assessment of cell-free and concentrated ascites reinfusion therapy during initial treatment for advanced ovarian cancer: A prospective cohort study.
J Obstet Gynaecol Res
; 47(4): 1536-1543, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33469981
12.
Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Cancer Sci
; 111(7): 2546-2557, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372453
13.
Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy.
Int J Clin Oncol
; 25(9): 1718-1725, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32447473
14.
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.
Int J Clin Oncol
; 25(3): 502-507, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31677021
15.
Human Papillomavirus (HPV) Genotyping Assay Suitable for Monitoring the Impact of the 9-Valent HPV Vaccine.
Tohoku J Exp Med
; 251(4): 287-294, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32759554
16.
Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.
Cancer Sci
; 110(12): 3811-3820, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31596999
17.
Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
Gynecol Oncol
; 154(3): 554-557, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285082
18.
Correlation between pre-operative and final histological diagnosis on endometrial cancer.
Int J Gynecol Cancer
; 29(5): 886-889, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30826751
19.
Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
Gynecol Oncol
; 147(3): 585-588, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055558
20.
A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
Jpn J Clin Oncol
; 46(6): 517-21, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26977055